BVS vs DAL · rev $573.3M vs P/E 12, rev $61.64B
Bioventus Inc (BVS) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
BVS currently screens at market cap $495.1M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the BVS and DAL stock pages for the full models.
Not investment advice.